# Rituximab (Genetical Recombination) I.V. Infusion 500mg (リツキサン点滴静注５００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291407A2031). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291407A2031
- **Product name (Japanese):** リツキサン点滴静注５００ｍｇ
- **English title:** Rituximab (Genetical Recombination) I.V. Infusion 500mg
- **Active ingredient:** リツキシマブ（遺伝子組換え）
- **Active ingredient (INN):** Rituximab (Genetical Recombination)
- **Strength / unit:** ５００ｍｇ５０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** 全薬工業
- **NHI price (reference only):** JPY 78002 per ５００ｍｇ５０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291407A2031
- **JSON:** https://www.nifujipharma.com/api/drugs/4291407A2031

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Rituximab%20(Genetical%20Recombination)%20I.V.%20Infusion%20500mg%20(%E3%83%AA%E3%83%84%E3%82%AD%E3%82%B5%E3%83%B3%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%95%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291407A2031#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Rituximab (Genetical Recombination)

- [Rituximab (Genetical Recombination) I.V. Infusion 100mg (リツキサン点滴静注１００ｍｇ)](https://www.nifujipharma.com/drugs/4291407A1035) — １００ｍｇ１０ｍＬ１瓶, 全薬工業